Literature DB >> 19330833

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

Anders Näsman1, Per Attner, Lalle Hammarstedt, Juan Du, Mathilda Eriksson, Geraldine Giraud, Sofie Ahrlund-Richter, Linda Marklund, Mircea Romanitan, David Lindquist, Torbjörn Ramqvist, Johan Lindholm, Pär Sparén, Weimin Ye, Hanna Dahlstrand, Eva Munck-Wikland, Tina Dalianis.   

Abstract

In the county of Stockholm, between 1970 and 2002, we have previously reported a 3-fold parallel increase in the incidence of tonsillar squamous cell carcinoma (SCC) and the proportion of human papillomavirus (HPV) positive tonsillar SCC. Here, we have followed the above parameters in all patients (n = 120) diagnosed with tonsillar SCC during 2003-2007 in the same area, and also in correlation to our previous data. Ninety-eight pretreatment biopsies were available and presence of HPV DNA and HPV-16 E6 and E7 RNA were tested by polymerase chain reaction (PCR) and RT-PCR. Incidence data were obtained from the Swedish Cancer Registry. Data reported from 1970 to 2002 were also obtained for comparison. HPV DNA was present in 83 of 98 (85%) of the tonsillar SCC biopsies from 2003 to 2007 and 77 of these were HPV-16 positive. HPV-16 E6 and E7 RNA were found in 98% of 52 analyzed HPV-16 positive cases. The proportion of HPV-positive cancers had significantly increased both from 1970 to 2007 (p < 0.0001) as well from 2000 to 2007 (p < 0.01), with 68% (95% confidence interval (CI), 53-81) 2000-2002; 77% (95% CI, 63-87) 2003-2005; and 93% (95% CI, 82-99) 2006-2007. The incidence rate of HPV-positive tumors almost doubled each decade between 1970 and 2007, in parallel with a decline of HPV-negative tumors. In conclusion, the incidence of HPV-positive cancers is still increasing in the County of Stockholm, suggesting an epidemic of a virus-induced carcinoma, with soon practically all tonsillar SCC being HPV positive, as in cervical cancer. Copyright 2009 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330833     DOI: 10.1002/ijc.24339

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  243 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

Review 2.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

3.  p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.

Authors:  James S Lewis; Wade L Thorstad; Rebecca D Chernock; Bruce H Haughey; James H Yip; Qin Zhang; Samir K El-Mofty
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

Review 4.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 5.  [Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications].

Authors:  M Reuschenbach; S Wagner; N Würdemann; S J Sharma; E-S Prigge; M Sauer; A Wittig; C Wittekindt; M von Knebel Doeberitz; J P Klussmann
Journal:  HNO       Date:  2016-07       Impact factor: 1.284

6.  Prevalence of oral HPV infection in the United States, 2009-2010.

Authors:  Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi
Journal:  JAMA       Date:  2012-01-26       Impact factor: 56.272

7.  Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Snehal G Patel; Richard B Hayes; Ian Ganly
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

8.  p16 as a prognostic factor for the response to induction chemotherapy in advanced hypopharyngeal squamous cell carcinoma.

Authors:  Joon Kyoo Lee; Kyung-Hwa Lee; Sun-Ae Kim; Sun Seog Kweon; Sang-Hee Cho; Hyun-Jeong Shim; Woo-Kyun Bae; Ik-Joo Chung; Woong-Ki Chung; Tae Mi Yoon; Sang Chul Lim; Dong Hoon Lee
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

9.  Epidemiology of head and neck squamous cell cancer among HIV-infected patients.

Authors:  Gypsyamber Dʼsouza; Thomas E Carey; William N William; Minh Ly Nguyen; Eric C Ko; James Riddell; Sara I Pai; Vishal Gupta; Heather M Walline; J Jack Lee; Gregory T Wolf; Dong M Shin; Jennifer R Grandis; Robert L Ferris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

10.  MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.

Authors:  Seija I Vento; Lauri Jouhi; Hesham Mohamed; Caj Haglund; Antti A Mäkitie; Timo Atula; Jaana Hagström; Laura K Mäkinen
Journal:  Virchows Arch       Date:  2018-05-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.